Lyme Disease Treatment Market to Reach $1.6 Billion, Globally, by 2031 at 8.4% CAGR: Allied Market Research

Growing prevalence of lyme disease in humans and animals across the world, increase in public knowledge of tick-borne infections and veterinary care, and fast advancements in lyme disease research drive the growth of the global lyme disease treatment market

PORTLAND, Ore., Sept. 12, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Lyme Disease Treatment Market by Treatment (Medication, Tick Removal), by Administration Route (Oral, Injectable, Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online): Global Opportunity Analysis and Industry Forecast, 2022-2031." According to the report, the global lyme disease treatment market accrued a sum of $737.5 million in 2021, and is estimated to reach $1.6 billion by 2031, witnessing a CAGR of 8.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Drivers and Opportunities

Growing prevalence of lyme disease across the world, increase in public knowledge of tick-borne infections and veterinary care, and fast advancements in Lyme disease research and diagnostics drive the growth of the global lyme disease treatment market. However, increase in number of generic medications for lyme disease treatment hinder the market growth. On the other hand, increased government efforts in raising awareness regarding animal care and the dangers of Lyme disease present new opportunities in the market in the coming years.

Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/31880

Covid-19 Scenario

• The COVID-19 pandemic had a negative impact on the lyme disease treatment market. Healthcare workers' focus shifted toward the diagnosis and treatment of Covid-19 patients, which delayed outpatient visits for other potential reasons in the process. Patients with Lyme disease symptoms were asked to cancel their tests as coronavirus cases started to rise.
• Moreover, people suffering from lyme disease were hesitant to visit hospitals due to fear of contracting COVID-19. All these issues severely hampered the global lyme disease treatment market expansion.
• The current goal of governments and health ministries of various countries is to adopt immediate actions to reduce the number of Lyme disease cases.

The administration route segment to hold the lion's share during the forecast period

Based on administration route, the oral segment held the largest share in 2021, grabbing nearly half of the global lyme disease treatment market, and is expected to maintain a noteworthy growth during the forecast period. This is due to the availability of a large number of drug products that are delivered orally. However, the injectable segment is projected to witness the fastest CAGR of 9.1% from 2022 to 2031, as injectable are safe, require little downtime, and are cost-effective.

The medication segment to maintain its leadership status during the forecast period

Based on treatment, the medication segment contributed to the largest market share of nearly three-fourths of the global lyme disease treatment market in 2021, and is likely to maintain its dominance during the forecast period. Moreover, the same segment is expected to exhibit the highest CAGR of 8.5% from 2022 to 2031. This is because medication plays a vital role in tick removal, fighting illness and protect the subsequent infections.

Purchase Inquire:
https://www.alliedmarketresearch.com/purchase-enquiry/31880

The hospital pharmacies segment to maintain its leadership status during the forecast period

Based on distribution channel, the hospital pharmacies segment contributed to the largest share of more than half of the global lyme disease treatment market in 2021, and is expected to maintain its leadership status during the forecast period. This is owing to the significant rise in the number of hospital visits and patient admissions. However, the online segment is expected to exhibit the highest CAGR of 9.0% from 2022 to 2031. This is because the online platform offers greater anonymity for the consumers, lower transaction, product cost, and increased access.

Asia-Pacific to grow at the fastest rate by 2031

Based on region, North America held the highest market share in 2021, accounting for more than three-fifths of the global lyme disease treatment market, and is expected to maintain its dominance during the forecast period, owing to an increase in the incidence of vector-borne diseases in the region. However, Asia-Pacific is projected to manifest the fastest CAGR of 9.7% during the forecast period, owing to the growing awareness regarding lyme disease, its treatment cost, and a rise in disposable income in the region.

Leading Market Players

• Galaxo SmithKline Plc.
• Pfizer, Inc.
• Novartis AG
• Mayne Pharma
• Sun Pharmaceuticals Industries Inc.
• Lupin Pharmaceuticals, Inc.
• Orion Corporation
• Perrigo Company Plc.
• Chartwell Pharmaceuticals
• Almirall, LLC

The report analyzes these key players of the global lyme disease treatment market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):

Digital Therapeutics Market by Product (Software and Devices), Sales Channel (Business-to-Business and Business-to-Consumers), Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others: Global Opportunity Analysis and Industry Forecast, 2022-2031

Veterinary Medicine Market by Product (Drugs, Vaccines, and Medicated Feed Additives), Route of Administration (Oral Route, Parenteral Route, and Topical Route), Animal Type (Companion Animals and Livestock Animals), and Distribution Channel (Veterinary Hospitals Pharmacies, and Retail Veterinary Pharmacies): Global Opportunity Analysis and Industry Forecast, 2022-2031

3D Cell Culture Market by Product (Scaffold-Based Platforms, Scaffold-Free Platforms, Gels, Bioreactors, Microchips, and Services), Application (Cancer Research, Stem Cell Research, Drug Discovery, and Regenerative Medicine), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2022-2031

Intravenous Immunoglobulin (IVIG) Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre syndrome, and Others) and Type (IgG, IgA, IgM, IgE, and IgD): Global Opportunity Analysis and Industry Forecast, 2022-2031

Computer-Aided Drug Discovery Market by Type (Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches), by Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others), by End User (Pharmaceutical Companies, Biotechnology Companies, Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2022-2031

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg